Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Defensins and mucosal protection.

Y R Mahida1, R N Cunliffe

  • 1Division of Gastroenterology, Institute of Infection, Immunity and Inflammation, University of Nottingham and University Hospital, Queen's Medical Centre, Nottingham NG7 2UH, UK.

Novartis Foundation Symposium
|January 27, 2005
PubMed
Summary

Epithelial cells in the gut produce antimicrobial peptides like human defensins (HD5, HD6, HBD1, HBD2) to protect against bacteria. These defensins also play a role in regulating immune responses, particularly in inflammatory bowel disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New concepts in C. difficile management.

British medical bulletin·2019
Same author

Toll-like receptor expression in crypt epithelial cells, putative stem cells and intestinal myofibroblasts isolated from controls and patients with inflammatory bowel disease.

Clinical and experimental immunology·2014
Same author

Differential binding and internalization of Clostridium difficile toxin A by human peripheral blood monocytes, neutrophils and lymphocytes.

Scandinavian journal of immunology·2011
Same author

Primary human colonic myofibroblasts are resistant to Clostridium difficile toxin A-induced, but not toxin B-induced, cell death.

Infection and immunity·2011
Same author

Expression profiling of Wnt family of genes in normal and inflammatory bowel disease primary human intestinal myofibroblasts and normal human colonic crypt epithelial cells.

Inflammatory bowel diseases·2010
Same author

The stem cells of small intestinal crypts: where are they?

Cell proliferation·2009

Area of Science:

  • Gastroenterology
  • Immunology
  • Microbiology

Background:

  • The gastrointestinal tract harbors a complex bacterial population, necessitating host defense mechanisms.
  • Epithelial cells are crucial in mediating protective responses against resident microorganisms.
  • Antimicrobial peptides, particularly defensins, are increasingly recognized for their role in gut immunity.

Purpose of the Study:

  • To investigate the role of enteric alpha-defensins (HD5, HD6) and human beta-defensins (HBD1, HBD2) in intestinal epithelial defense.
  • To understand the expression patterns and processing of these defensins in health and inflammatory bowel disease (IBD).
  • To explore the potential immunomodulatory functions of defensins in the context of IBD.

Main Methods:

  • Analysis of defensin expression in intestinal epithelial cells, including Paneth cells.
  • Investigation of the processing of alpha-defensins (HD5) from precursor to mature forms.
  • Examination of defensin expression changes in inflammatory bowel disease models or patients.

Main Results:

  • Enteric alpha-defensins (HD5, HD6) are expressed by Paneth cells, with HD5 requiring processing.
  • Human beta-defensin 1 (HBD1) is constitutively expressed, while HBD2 expression is induced in inflammatory bowel disease.
  • Defensins (HBDs) exhibit chemotactic properties for immune cells like dendritic cells and T cells.

Conclusions:

  • Intestinal epithelial cells utilize defensins as a key component of innate immunity against luminal bacteria.
  • Defensins may bridge innate and adaptive immunity by influencing immune cell migration and function.
  • Altered expression of defensins in inflammatory bowel disease suggests a role in disease pathogenesis and regulation.

Related Experiment Videos